This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/AHFS/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/chemspider/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/chebi/
n19http://bio2rdf.org/drugbank:
n16http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/pharmgkb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/wikipedia/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/kegg-compound/
n18http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB01370/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#
n3http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB01370
rdf:type
n5:Drug
n5:description
A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. [PubChem]
n5:group
approved
owl:sameAs
n18:DB01370 n19:DB01370
dcterms:title
Aluminium
adms:identifier
n7:28984 n8:4514248 n10:46504765 n12:C06264 n13:5359268 n14:DB01370 n15:Aluminium n16:PA164760864
n5:mechanismOfAction
Aluminum Acetate is an astringent. An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application. The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied. Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete's foot.
n5:synonym
Aluminium 13Al Al Aluminio Aluminum
n3:hasAHFSCode
n4:88-29-00%2A n4:20-12-12 n4:34-00-00 n4:92-02-00%2A n4:84-92-00 n4:56-04-00 n4:84-04-92 n4:84-12-00 n4:52-28-00
n5:synthesisReference
Bela Czegledi, Mihaly Csovari, Miklos Erdelyi, Lajos Streker, Istvan Toth, Katalin Szabo nee Mogyorosi, Szilard Riederauer, Geza Szentgyorgyi, "Process for producing alumina and ferric oxide from aluminium carriers with high iron and silicon content." U.S. Patent US4366129, issued 1876.
n5:IUPAC-Name
n9:271B4345-363D-11E5-9242-09173F13E4C5
n5:InChI
n9:271B434B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n9:271B434A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n9:271B4347-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n9:271B4348-363D-11E5-9242-09173F13E4C5
n5:SMILES
n9:271B4349-363D-11E5-9242-09173F13E4C5
n5:logP
n9:271B4344-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n9:271B4351-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n9:271B4352-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n9:271B434C-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n9:271B434D-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n9:271B434F-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n9:271B434E-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n9:271B4350-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
7429-90-5
n5:Bioavailability
n9:271B4355-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n9:271B4357-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n9:271B4358-363D-11E5-9242-09173F13E4C5
n5:Melting-Point
n9:271B4359-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n9:271B4354-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n9:271B4353-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n9:271B4356-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n9:271B4346-363D-11E5-9242-09173F13E4C5